Rx Summit

The opioid crisis is the deadliest drug epidemic the United States has ever seen. Over 130 Americans die every day from opioid-related causes as first responders and public health officials struggle to keep up.

ICF is working in partnership with the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration, and others, to address this tragic epidemic. ICF’s work to attack the causes of overdose deaths will be highlighted at the 2022 Rx Summit in Atlanta.

Our expert staff will present on the incorporation of lived experience in Substance Use Disorder/Opioid Use Disorder (SUD/OUD) response, sharing essential elements and real-world engagement examples of our work in this area.

We will also discuss recent trends in fatal and nonfatal overdoses—related to all opioids and synthetic opioids across population groups—based on the most up-to-date available data.

Poster presentation

Meaningful Incorporation of Lived Experience into SUD/OUD Response—Foundations for a Framework

Syreeta Skelton-Wilson | Senior Manager, Research Science, ICF, Atlanta, GA

This poster presentation discusses essential elements and cites real-world engagement examples of lived experience in SUD/OUD response. Engagement examples are tied into assessment of needs, planning and design, or implementation at the intervention, program, organizational, or policy level. This practical guidance will assist public health professionals, policy makers, practitioners, epidemiologists, and others to take the necessary steps to incorporate lived experience into OUD/SUD response.

Join our panel discussion

Tuesday, April 19, 11:15 AM-12:30 PM

Fentanyl Test Strips (FTS) for Harm Reduction and Overdose Prevention: Research and Legislative Update

Sofia Campos, MPH, BSN| Lead Research Scientist, ICF, Atlanta, GA

ICF’s Sofia Campos will explain the importance of FTS availability within communities to prevent overdose. Participants will learn the recent trends in fatal and nonfatal overdoses related to all opioids and synthetic opioids across population groups based on the most up-to-date available data on fatal and nonfatal opioid-related overdoses using the CDC’s National Vital Statistics System (NVSS, 2016-2020) and morbidity data from National Hospital Ambulatory Medical Care Survey (NHAMCS, 2016-2019).

For information, contact Michael Greenwell

michael.greenwell@icf.com